Riskpilot← Back to searchSign inGet full accessNITTEDAL DYREKLINIKK AS
ASActiveOrg 913857410Slattum Terrasse 2, 1480 SlattumVeterinary activities · NACE 7500Est. 20149 employees
Revenue 2024
NOK 11,4M
+21% vs 2023
EBITDA margin
26.5%
+27% vs 2023
Equity ratio
30.1%
Financial strength
Net profit 2024
NOK 2,3M
+28% vs 2023
| Revenue | NOK 11,4M | +21% |
| EBITDA | NOK 3M | +27% |
| Net profit | NOK 2,3M | +28% |
| Total assets | NOK 4,4M | +22% |
| Equity | NOK 1,3M | -24% |
| Employees | 9 | — |
Legal name
NITTEDAL DYREKLINIKK AS
Org number
913857410
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
7. juli 2014
Share capital
NOK 30 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av veterinærtjenester samt det som naturlig står i forbindelse med dette.
Address
Slattum Terrasse 2, 1480 Slattum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 082 | 6 043 | 7 264 | 9 347 | 11 357 |
| Staff expenses | −2 767 | −2 574 | −2 844 | −3 582 | −4 402 |
| EBITDA | 988 | 1 091 | 1 760 | 2 375 | 3 012 |
| Depreciation & amort. | −63 | −63 | −62 | −130 | −123 |
| EBIT | 925 | 1 028 | 1 698 | 2 245 | 2 889 |
| Net financials | 24 | 11 | 30 | 30 | 62 |
| Profit before tax | 949 | 1 039 | 1 728 | 2 275 | 2 951 |
| Tax | 209 | 235 | 389 | 481 | 650 |
| Net profit | 740 | 804 | 1 339 | 1 794 | 2 302 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 291 | 4 030 | 3 115 | 3 613 | 4 405 |
| Equity | 2 348 | 1 552 | 1 397 | 1 737 | 1 326 |
| Long-term debt | 0 | 0 | 0 | 0 | 22 |
| Short-term debt | 943 | 2 478 | 1 717 | 1 876 | 3 057 |
| Total debt | 943 | 2 478 | 1 717 | 1 876 | 3 079 |
EBITDA margin
26.5%
This company
15.8%
Market median
+68% vs market
20202024
Equity ratio
30.1%
This company
38.2%
Market median
+21% vs market
20202024
Return on equity
173.6%
This company
18.4%
Market median
+843% vs market
20202024
Net profit margin
20.3%
This company
8.1%
Market median
+151% vs market
20202024
Asset turnover
2.58×
This company
1.12×
Market median
+130% vs market
20202024
Debt / equity
2.32×
This company
0.62×
Market median
-274% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (1) | ||
ØJ Chief Executive Officer | Chief Executive Officer | 2014 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dogtor Invest As
NITTEDAL DYREKLINIKK AS Board members of NITTEDAL DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Sundqvist Aune | Chief Executive Officer | 0 companies |
| Øyvind Jamne | Chief Executive Officer | 0 companies |
| Nina Helene Sundqvist | Board of Directors | 0 companies |
| Oscar Mathias Brakstad | Board of Directors | 0 companies |
| Lasse Aune | Board of Directors | 0 companies |